| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 77221 |
cas:663599-10-8，DMAC-SPP |
117 |
zyl |
2024-12-19 |
| 77222 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
158 |
h |
2024-12-19 |
| 77223 |
PEG-pGlu(DOTA)8-LA4 |
65 |
h |
2024-12-19 |
| 77224 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
154 |
zyl |
2024-12-19 |
| 77225 |
DOTA-Hyd-TRP PET示踪剂 |
120 |
h |
2024-12-19 |
| 77226 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
168 |
h |
2024-12-19 |
| 77227 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
91 |
zyl |
2024-12-19 |
| 77228 |
DOTA-ALN DOTA-阿仑膦酸盐 |
97 |
h |
2024-12-19 |
| 77229 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
158 |
h |
2024-12-19 |
| 77230 |
cas:906564-59-8，Propargyl-C2-NHS ester |
106 |
zyl |
2024-12-19 |
| 77231 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
96 |
h |
2024-12-19 |
| 77232 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
88 |
zyl |
2024-12-19 |
| 77233 |
DOTA结合肽功能化金纳米粒子 |
104 |
h |
2024-12-19 |
| 77234 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
132 |
h |
2024-12-19 |
| 77235 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
126 |
zyl |
2024-12-19 |
| 77236 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
79 |
zyl |
2024-12-19 |
| 77237 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
77 |
zyl |
2024-12-19 |
| 77238 |
cas:2353409-70-6 MMAF-methyl ester |
181 |
zyl |
2024-12-19 |
| 77239 |
DOTA-ipilimumab 螯合剂DOTA缀合单克隆抗体ipilimumab |
108 |
h |
2024-12-19 |
| 77240 |
双功能单膦酸Ln-DOTA衍生物 |
120 |
h |
2024-12-19 |
| 77241 |
Cu-DOTA-阿伦膦酸盐 Cu-DOTA-alendronate |
110 |
h |
2024-12-19 |
| 77242 |
Mc-3377的介绍 |
91 |
zyl |
2024-12-19 |
| 77243 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF的介绍 |
91 |
zyl |
2024-12-19 |
| 77244 |
(DOTA)n-PAMAM-[尼妥珠单抗-F(ab’)2]的缀合物 |
97 |
h |
2024-12-19 |
| 77245 |
cas:2055041-39-7 Mal-PEG4-Val-Cit-PAB-OH |
129 |
zyl |
2024-12-19 |
| 77246 |
DBCO-PEG3-Val-Cit-PAB-PNP的介绍 |
142 |
zyl |
2024-12-19 |
| 77247 |
(DOTA)5-十氢赖氨酸(DOTA)5-decalysine |
140 |
h |
2024-12-19 |
| 77248 |
DOTA-HPMA缀合物 DOTA共轭N-(2-羟丙基)甲基丙烯酰胺聚合物 |
103 |
h |
2024-12-19 |
| 77249 |
G3-cNGR肽缀合物 |
134 |
h |
2024-12-19 |
| 77250 |
DOTA-USMSN DOTA偶联介孔二氧化硅纳米颗粒 |
100 |
h |
2024-12-19 |
| 77251 |
Gd-DOTA-CC9 环肽CC9偶联Gd-DOTA |
151 |
h |
2024-12-19 |
| 77252 |
DOTA-尼妥珠单抗缀合物 DOTA-NIM |
78 |
h |
2024-12-19 |
| 77253 |
DOTA功能化杯[4]芳烃 DOTA-Calix[4]arenes |
96 |
h |
2024-12-19 |
| 77254 |
DOTA-Modified 2-Hydroxypropyl-β-Cyclodextrin/4-Sulfobutyl Ether-β-Cyclodextrin-Based Polyrotaxanes |
69 |
h |
2024-12-19 |
| 77255 |
CQDs-DOTA-Eu 铕-DOTA螯合物功能化碳量子点 |
149 |
h |
2024-12-19 |
| 77256 |
DOTA-曲普瑞林 DOTA-TRP |
93 |
h |
2024-12-19 |
| 77257 |
DOTA-Boron-ENPY 大环DOTA偶联16氨基酸的NPY衍生物 |
114 |
h |
2024-12-19 |
| 77258 |
DOTA-CDP1 DOTA功能化凯萨林菌素衍生肽 |
124 |
h |
2024-12-19 |
| 77259 |
Fe3O4@SiO2-APTES-DOTA-Teniposide 氧化铁@二氧化硅核壳纳米粒子偶联DOTA分子共轭替尼泊苷药物 |
154 |
h |
2024-12-19 |
| 77260 |
DOTA-吉西他滨 DOTA-gem |
171 |
h |
2024-12-19 |
| 77261 |
DOTA缀合的TMVP1肽 DOTA-TMVP1 |
75 |
h |
2024-12-19 |
| 77262 |
DOTA-NHS-ester偶联16-氨基-1-十六烷硫醇盐酸盐 |
98 |
h |
2024-12-19 |
| 77263 |
DOTA-ST8950 DOTA偶联碘代氨基酸的类似物ST8950 |
106 |
h |
2024-12-19 |
| 77264 |
DOTA官能化酞菁纳米点 DOTA‐Functionalized Phthalocyanine Nanodots |
99 |
h |
2024-12-19 |
| 77265 |
DOTA-D-Phe1-Tyr3-octreotide preparations |
79 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询